Literature DB >> 8355789

Helper T-cell development in the absence of CD4-p56lck association.

N Killeen1, D R Littman.   

Abstract

The CD4 and CD8 glycoproteins are expressed on helper and cytoxic T lymphocytes, respectively, and have important functions in the differentiation and activation of these cells. These molecules are thought to participate in signal transduction by binding to the same class II or class I major histocompatibility complex molecules that are engaged by the T-cell antigen receptor. The cytoplasmic domains of both CD4 and CD8 interact with the protein tyrosine kinase p56lck (refs 14-17), an essential participant in thymocyte maturation and T-cell activation. This interaction is required for effective in vitro responses to antigen, suggesting that signalling through p56lck is a major function of CD4 and CD8. Here we investigate the role of the CD4-p56lck interaction during T-lymphocyte development by expressing wild-type and truncated products of CD4 transgenes in mice that lack endogenous CD4 and hence have defective helper-cell development. We find that transgenic CD4, which cannot associate with p56lck, can nevertheless rescue the helper-cell lineage when overexpressed. This result indicates that the contribution of CD4 to lineage development need not involve signalling through p56lck, and provides insight into the general function of CD4 and CD8.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355789     DOI: 10.1038/364729a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  23 in total

1.  Functional evidence for TCR-intrinsic specificity for MHCII.

Authors:  Heather L Parrish; Neha R Deshpande; Jelena Vasic; Michael S Kuhns
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-01       Impact factor: 11.205

2.  The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.

Authors:  Paul M Waterman; Susanne Marschner; Erin Brandl; John C Cambier
Journal:  Immunol Lett       Date:  2012-02-24       Impact factor: 3.685

Review 3.  CD4 on the road to coreceptor status.

Authors:  Dario A A Vignali
Journal:  J Immunol       Date:  2010-06-01       Impact factor: 5.422

4.  Molecular and cellular analysis of human immunodeficiency virus-induced apoptosis in lymphoblastoid T-cell-line-expressing wild-type and mutated CD4 receptors.

Authors:  L Moutouh; J Estaquier; D D Richman; J Corbeil
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Requirement for p56lck tyrosine kinase activation in T cell receptor-mediated thymic selection.

Authors:  K Hashimoto; S J Sohn; S D Levin; T Tada; R M Perlmutter; T Nakayama
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

6.  Kinetics and extent of T cell activation as measured with the calcium signal.

Authors:  C Wülfing; J D Rabinowitz; C Beeson; M D Sjaastad; H M McConnell; M M Davis
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

7.  An alternative way of CD4 and CD8 association with protein kinases of the Src family.

Authors:  T Cinek; I Hilgert; V Horejsí
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

8.  Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge.

Authors:  Linda S Wyatt; Patricia L Earl; Leigh Anne Eller; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-11       Impact factor: 11.205

9.  The CD4 and CD3δε Cytosolic Juxtamembrane Regions Are Proximal within a Compact TCR-CD3-pMHC-CD4 Macrocomplex.

Authors:  Caleb R Glassman; Heather L Parrish; Neha R Deshpande; Michael S Kuhns
Journal:  J Immunol       Date:  2016-05-02       Impact factor: 5.422

10.  HD mice: a novel mouse mutant with a specific defect in the generation of CD4(+) T cells.

Authors:  V P Dave; D Allman; R Keefe; R R Hardy; D J Kappes
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.